XXXX due to @entity3069 complex in an immunocompetent host: a case report.

@entity1 @entity3110 @entity4767 @entity932 @entity404 @entity227 @entity4581 @entity645 @entity358 @entity3069 @entity1215 @entity892 @entity19262 @entity10
BACKGROUND: @entity3069 complex (MAC) is a ubiquitous pathogen, widely distributed in the environment including water, soil and animals. It is an uncommonly encountered clinical pathogen; primarily causing @entity358 in @entity1 with underlying @entity358 or disseminated disease in immunocompromised hosts. Sporadically, extra- @entity358 have been documented including involvement of the liver, spleen, skin, soft tissue and lymph nodes. @entity4767 due to MAC are exceedingly rare and carry a poor prognosis. Additionally, such infections are largely reported in @entity1 infected with @entity645 . Herein we report the first case of @entity932 due to MAC in an immunocompetent @entity1 with a normal @entity404 count and negative @entity645 status. CASE PRESENTATION: A previously healthy 40-year-old male presented to us with progressively worsening CNS symptoms. The @entity1 's presentation was uncharacteristic of @entity19262 in immunocompetent hosts, as he developed subacute, progressive symptoms that included severe @entity10 , @entity227 , and @entity892 , without any pulmonary or systemic manifestations. Neuroimaging revealed multiple ring-enhancing lesions, which required neurosurgical intervention. MAC was the only pathogen that grew from intraoperative tissue cultures. The @entity1 was subsequently treated with a 12-month regimen consisting of @entity4581 , @entity3110 , and @entity1215 , with successful clinical resolution. CONCLUSION: Our findings indicate that it is important to consider rare infections such as MAC in immunocompetent @entity1 , regardless of atypical symptoms. Despite the severity of this infection, with timely diagnosis effective treatment is available.
